Autism Spectrum Disorders
1st Edition
Published on 28. May 2003
Book
Hardback
338 pages
978-0-8247-0715-6 (ISBN)
Description
Presenting examples that highlight the efficacy of the dimensional approach in autism spectrum research, this reference analyzes the three core symptom domains: social, communication, and repetitive/compulsive behavior, to determine the neurobiology, pathophysiology and treatment of specific autistic components and improve assessment and intervention regimens for a wide range of pervasive developmental disorders.
More details
Language
English
Place of publication
Bosa Roca
United States
Publishing group
Taylor & Francis Inc
Target group
Professional and scholarly
College/higher education
Dimensions
Height: 254 mm
Width: 178 mm
Weight
726 gr
ISBN-13
978-0-8247-0715-6 (9780824707156)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Person
Content
The clinical condition: autism - diagnosis and epidemiology, Fred R. Volkmar, Kathleen Koenig, and Malia McCarthy; core symptoms, related disorders and course of autism, Eric Hollander and Caralynn V. Nowinski. Assessment: autism screening andneurodevelopmental assessment, Sarah J. Spence and Daniel H. Geschwind; assessment and early identification of autistic spectrum and other disorders of relating and communicating, Stanley I. Greenspan and Serena Wieder; cognitive and neuropsychologicalassessment of children with autism spectrum disorders, Audrey F. King, Ronald R. Rawitt, Katherine C. Barboza, and Eric Hollander; assessment and diagnosis of pervasive development disorder, Cecelia McCarton. The neurobiology of autism: molecular geneticsof autism, Jennifer Reichert, Mario Kilifarski, Irina Bespalova, Nicolas Ramoz, and Joseph D. Buxbaum; immune dysfunction in autism, Gina Delgiudice-Asch and Eric Hollander; autism and environment toxins, Martin Evers, Sherie Novotny, and Eric Hollander;neurobiology of serotonin function in autism, Christopher J. McDougle, David J. Posey, and Marc N. Potenza; autism, serotonin and the Cerebellum - a new, comprehensive hypothesis, Donatella Marazziti. Psychopharmacological treatments: antidepressants andanticonvulsants/mood stabilizers in the treatment of autism, Sherie Novotny and Eric Hollander; use of atypical antipsychotics in autism, David Posey and Christopher J. McDougle; treatment of seizures in children with autism spectrum disorders, RobertoTuchman; treatment of movement disorders in autism, James Robert Brosi; alternative biological treatments for autism, Charles Cartwright and Rachael Power. Other treatment approaches: behavioral assessment and treatment, Tristram Smith and CarolineMagyar; educational intervention - inclusion vs self-contained classes, Audrey F. King; consumer advocacy and autism, John Maltby; autism - a personal perspective, Temple Grandin; future trends, Eric Hollander and Ronald R. Rawitt.